Izotropic Corporation IZOZF
OTC PK
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 447.50K | 1.15M | 1.20M | 1.07M | 1.00M |
| Depreciation & Amortization | 24.40K | 23.50K | 27.30K | 34.30K | 35.70K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 998.40K | 1.74M | 1.74M | 1.57M | 1.53M |
| Operating Income | -998.40K | -1.74M | -1.74M | -1.57M | -1.53M |
| Income Before Tax | -1.59M | -1.81M | -1.96M | -1.64M | -2.25M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.59 | -1.81 | -1.96 | -1.64 | -2.25 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.59M | -1.81M | -1.96M | -1.64M | -2.25M |
| EBIT | -998.40K | -1.74M | -1.74M | -1.57M | -1.53M |
| EBITDA | -995.90K | -1.73M | -1.73M | -1.54M | -1.50M |
| EPS Basic | -0.02 | -0.03 | -0.03 | -0.03 | -0.04 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.02 | -0.01 | -0.02 |
| EPS Diluted | -0.02 | -0.03 | -0.03 | -0.03 | -0.04 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.02 | -0.01 | -0.02 |
| Average Basic Shares Outstanding | 264.51M | 258.37M | 251.49M | 243.25M | 234.73M |
| Average Diluted Shares Outstanding | 264.51M | 258.37M | 251.49M | 243.25M | 234.73M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |